Vaccines are one of the greatest medical advances in history. This strategy is now being applied to the treatment and prevention of Alzheimer’s. We…
As part of our mission to bring you trustworthy information that’s easy to understand, our editorial team hosts weekly LiveTalks with experts, advocates and…
Alzheimer’s is a notoriously difficult disease to identify with certainty. By the time a patient receives a diagnosis, its pathology in the brain is…
What’s the difference between treating Alzheimer’s symptoms and modifying the disease? Despite decades of research, the underlying cause of Alzheimer’s continues to evade scientists….
Protollin, a new vaccine for Alzheimer’s that is administered nasally, heads to human clinical trials. Through the incredible power of our immune system, researchers…
Did you know that the brain is the most mysterious organ in the human body? Scientists still don’t know the majority of what there…
The years Rochelle Long has spent caring for her mother and aunt with Alzheimer’s have transformed her into an advocate for Paid Family Leave. …
Roughly two thirds of Americans with Alzheimer’s are women, but it isn’t exactly clear why the disease disproportionately impacts females. Given that age is…
We all have a vision for our future, aspirations we hope to achieve, whether it be in our careers, relationships or passions. A diagnosis…
Dementia care expert Teepa Snow shares guidance for making the holiday season more dementia-inclusive. For many families, the holidays mean mistletoe and holly, gift-giving,…
Analysts had high hopes for anti-amyloid drug Aduhelm — the first Alzheimer’s treatment approved by the FDA in nearly two decades and the first…
This article is part of the series Diversity & Dementia, produced by Being Patient with support provided by Eisai. Image: Luisa Echevarria at the MALDEF Chicago…
Since the early days of the novel coronavirus pandemic, researchers found that people living with Alzheimer’s were at a higher risk of severe COVID-19…
New clinical trials on memory loss interventions are currently enrolling healthy participants with key Alzhemier’s biomarkers as young as 55 years old. Tau and…
Despite the absence of disease-modifying treatments, the dementia rate in developed Western countries has actually declined in recent years. In fact, one study showed…